Skip to main content
. 2021 Apr 5;23(8):1522–1533. doi: 10.1038/s41436-021-01143-8

Table 1.

Demographic, molecular, and clinical data of MMA subjects.

# Age (years) Sex Race Transplant Gene Variant 1 Variant 2 Serum MMA (μM) % 1-13C3 dose metabolized (60 and 120 minutes) Tmax Δ13C (minutes) eGFR (mL/min/1.73 m2)
1 4.2 M W - MMUT c.1207C>T, p.Arg403Ter Unknown 774 12.51 18.97 30 110.1
2 5.4 M A - MMUT

c.1630_1631delinsTA

p.Gly544Ter

c.1106G>A, p.Arg369His 1,465 5.70 11.82 45 37.4
3 8.7 M M - MMUT c.682C>T, p.Arg228Ter c.322C>T, p.Arg108Cys 2,011 6.43c 13.92c 25 40.2
4 8.8 M W - MMUT c.1106G>A, p.Arg369His c.1324G>C, p.Ala442Pro 4,170 11.16 25.52 60 26.1
5 9.6 F B - MMUT c.91C>T, p.Arg31Ter c.250G>T, p.Glu84Ter 167 12.31 20.39 30 92.4
6 9.7 M W - MMUT c.52C>T, p.Gln18Ter c.1038_1040del, p.Leu347del 2,992 11.79 23.66 50 35.8
7 11.2 M W - MMUT c.1106G>A, p.Arg369His c.1324G>C, p.Ala442Pro 1,702 18.69 35.35 45 52.5
8 11.4 F B - MMUT c.682C>T, p.Arg228Ter c.1108A>C, p.Thr370Pro 258 8.89 N/A 50 118.3
9 11.7 M A - MMUT c.1560G>C, p.Lys520Asn c.1560G>C, p.Lys520Asn 596 16.07 31.14 45 60.2
10 11.8 M W - MMUT c.372_374dup p.Lys124_Asp125insGlu c.146_147ins279d 1,407 6.74 18.59 90 46.4
11 13.6 F H - MMUT c.1196_1197del p.Val399GlufsTer24 c.1106G>A, p.Arg369His 1,530 16.78 35.65 60 40.8
12 13.7 M W - MMUT c.1741C>T, p.Arg581Ter c.753+2T>A, p.splice 3,127 0.63c 7.20c 90 51.0
13 14.2 F W - MMUT c.1924G>C, p.Gly642Arg c.1924G>C, p.Gly642Arg 3,092 14.19c 31.25c 45 31.9
14 14.4 F A - MMUT c.682C>T, p.Arg228Ter c.785G>T, p.Ser262Ile 1,399 5.11 N/A 60 54.0
15 15.1 F W - MMUT c.91C>T, p.Arg31Ter

c.2053_2055dup

p.Leu685dup

341 21.38c 41.37c 45 51.1
16 15.6 F A - MMUT c.2179C>T, p.Arg727Ter c.2179C>T, p. Arg727Ter 2,147 6.21 16.81 60 31.9
17 15.7 F W - MMUT c.682C>T, p.Arg228Ter c.607G>A, p.Gly203Arg 551 8.52c 20.24c 40 54.0
18 16.5 F B - MMUT c.281G>T, p.Gly94Val c.1108A>C, p.Thr370Pro 234 19.85 34.55 30 36.9
19 16.8 F A - MMUT c.2078del, p.Gly693AspfsTer12 c.2078del, p.Gly693AspfsTer12 1,239 11.80 N/A 45 91.4
20 18.0 F W - MMUT c.323G>A, p.Arg108His c.1867G>C, p.Gly623Arg 400 6.38 N/A 60 58.3
21 18.8 F A - MMUT c.643G>T, p.Gly215Cys c.643G>T, p. Gly215Cys 1,094 16.35 29.96 30 47.8
22 19.5 F W - MMUT c.29dup, p.Leu10PhefsTer39 c.1658del, p.Val553GlyfsTer17 2,260 6.12c 15.09c 60 70.3
23 23.7 M B - MMUT c.1207C>T, p.Arg403Ter c.1360G>A, p.Gly454Arg 730 14.24 27.01 45 103.9
24 25.1 M W - MMUT c.572C>A, p.Ala191Glu c.655A>T, p.Asn219Tyr 2,123 6.19 15.81 60 38.5
25 28.1 F W - MMUT c.623_624del, p.Val208AlafsTer2 c.322C>T, p.Arg108Cys 1,157 14.29 25.94 52 33.1
26 33.7 M W - MMUT c.753+2T>A, p.splice c.1560+1G>T, p.splice 4,754 7.02 16.13 60 45.8
27 3.4 M W - MMUT c.372_374dup, p.Lys124_Asp125insGlu c.842T>C, p.Leu281Ser 36 39.46 48.23 15 76.0
28 4.8 M B - MMUT c.91C>T, p.Arg31Ter c.2150G>T, p.Gly717Val 19.5 18.42 26.93 25 22.3
29 5.9 M B - MMUT c.88C>T, p.Gln30Ter c.299A>G, p.Tyr100Cys 47 38.81 50.65 30 84.2
30 8.5 F B - MMUT c.88C>T, p.Gln30Ter c.299A>G, p.Tyr100Cys 266 28.89 40.86 33 108.2
31 9.2 M W - MMUT c.1181T>A, p.Leu394Ter c.1924G>C, p.Gly642Arg 37 37.70c 48.35c 20 109.6
32 9.6 F B MMUT c.2150G>T, p. Gly717Val c.281G>T, p.Gly94Val 168 28.47 48.82 30 91.9
33 4.2 M W - MMAA c.433C>T, p.Arg145Ter c.433C>T, p.Arg145Ter 80 35.03 43.09 15 87.7
34 9.9 M M - MMAA c.387C>A, p.Tyr129Ter c.593_596del, p.Thr198SerfsTer6 27 35.10c 51.79c 30 116.6
35 10.8 M W - MMAA c.433C>T, p.Arg145Ter c.1076G>A, p.Arg359Gln 36 34.90 52.86 15 101.9
36 13.7 M W - MMAA c.433C>T, p.Arg145Ter c.1075C>T, p.Arg359Ter 18.3 38.33c 54.39c 15 114.7
37 19.1 M W - MMAA c.433C>T, p.Arg145Ter c.433C>T, Arg145Ter 25 30.99 46.93 25 76.5
38 26.5 M W - MMAA c.433C>T, p.Arg145Ter c.593_596del, p.Thr198SerfsTer6 27 43.48 62.13 15 83.5
39 27.6 M W - MMAA c.440G>A, p.Gly147Glu c.450dup, p.Pro151AlafsTer19 50 28.38c 40.65c 30 78.5
40 41.8 M NAm - MMAA c.433C>T, p.Arg145Ter c.433C>T, p.Arg145Ter 29 34.04c 52.46c 25 97.4
41 47.2 M W - MMAA c.433C>T, p.Arg145Ter c.433C>T, p.Arg145Ter 56 31.81 47.74 30 85.5
42 3.7 M W - MMAB c.556C>T, p.Arg186Trp c.556C>T, p.Arg186Trp 805 8.35 16.34 40 36.1
43 34.1 M W - MMAB c.700C>T, p.Gln234Ter c.556C>T, p.Arg186Trp 279 32.75 47.22 17 39.3
44 17.2 F W KT MMUT c.927G>A, p.Trp309Ter c.983T>C p.Leu328Pro 2,477 9.41 21.1 60 23.4
45 18.1 F W KTa MMUT c.1924G>C, p.Gly642Arg c.1924G>C, p.Gly642Arg 688 13.42 28.75 60 58.9
46 32.2 M A KTb MMUT c.1741C>T, p.Arg581Ter c.1741C>T, p.Arg581Ter 445 12.30 24.49 30 70.8
47 37.5 M W KTa MMUT c.753+2T>A, p.splice c.1560+1G>T, p.splice 11,991 10.21 21.17 60 19.4
48 30.3 M M KT MMUT c.1760A>C, p.Tyr587Ser c.2150G>T, p.Gly717Val 263 25.15 36.43 25 78.9
49 27.1 F W KT MMAA c.433C>T, p.Arg145Ter c.586C>T, p.Arg196Ter 24 23.74 35.35 15 74.4
50 9.3 F W LKT MMUT c.682C>T, p.Arg228Ter c.1287C>G, p.Tyr429Ter 231 42.12 60.83 30 75.6
51 10.7 M M LKTa MMUT c.682C>T, p.Arg228Ter c.322C>T, p.Arg108Cys 121 34.31 45.76 20 77.7
52 11.7 F W LKT MMUT c.878A>C, p.Gln293Pro c.878A>C, p.Gln293Pro 154 36.52 47.50 10 44.9
53 13.0 M A LKT MMUT c.2179C>T, p.Arg727Ter c.2179C>T, p.Arg727Ter 96 31.80 42.74 15 80.9
54 13.5 M W LKT MMUT c.682C>T, p.Arg228Ter c.670G>T, p.Glu224Ter 385 27.88 48.78 20 50.7
55 15.7 M M LKT MMUT c.349G>T, p.Glu117Ter c.1038_1040del p.Leu347del 57 27.69 N/A 15 36.1
56 16.8 M W LTa MMUT c.1741C>T, p.Arg581Ter c.753+2T>A, p.splice 402 28.59 48.68 45 66.5
57 18.5 M W LKT MMUT c.1207C>T, p.Arg403Ter c.1105C>T, p.Arg369Cys 395 32.49 44.59 7 59.4
58 19.1 M A LT MMUT c.1106G>A, p.Arg369His c.1106G>A, p.Arg369His 1,021 42.45 54.41 10 33.2
59 23.9 F W LKTa MMUT c.29dup, p.Leu10PhefsTer38 c.1658del, p.Val553GlyfsTer17 9.5 35.65 49.43 15 69.8
60 30.4 F W pLKT MMUT c.1106G>A, p.Arg369His c.1106G>A, p.Arg369His 2,246 13.06 24.94 45 49.5
61 31.1 F W LKT MMUT c.2053_2055dup p.Leu685dup c.2053_2055dup p.Leu685dup 382 27.88 39.92 15 95.5
62 37.2 F H LKT MMUT c.826G>T, p.Glu276Ter c.1106G>A, p.Arg369His 255 24.88 36.57 20 49.8

Age at the time of stable isotope breath testing, as well as the molecular genetic analysis of the MMUT, MMAA, and MMAB genes and selected variables of the study are provided for each of the MMA subjects. Italics for mut0, bold for mut, bold and italics for cblB (MMAB) individuals and underline for cblA (MMAA). Serum MMA concentration is provided in micromole/liter, μmol/L or μM (normal levels <0.4 μmol/L).

A Asian, B Black, eGFR estimated glomerular filtration rate, H Hispanic, KT kidney transplant, LT liver transplant, LKT combined liver–kidney transplant, M Mixed race, MMA methylmalonic acid, N/A data not available, W White.

aSubjects tested before and after liver and/or kidney transplantation.

bRepeat study after a second KT.

cDesignates subjects where in vitro 14C-propionate fibroblast enzymatic assays were also available, provided in detail in Supplemental Table 1.

dIndividual 10 has a large 279- bp insertion comprised of an 183- bp segment that aligns to the 3’UTR of the ENO1 gene on chromosome 1 (8861004_8861186) and a ~96- bp polyA repeat that result in no detectable messenger RNA (mRNA) (PMID: 27233228).